20 %In the study conducted in Paris, MPXV was undetectable in blood from about 20% of patients at diagnosis.
NigeriampoxHAL · Unilimdocument de 102 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
8 823 evidences · page 70 / 353
20 %In the study conducted in Paris, MPXV was undetectable in blood from about 20% of patients at diagnosis.
NigeriampoxHAL · Unilimdocument de 102 observations
1,4 unitlessMean HOMA-IR values were 1.4 ± 2.1 in obese diabetics.
Nigeriadiabète de type 2publié 2026BMC research notesPubMeddocument de 6 observations
74,5 %At a predicted probability threshold of 0.745, the GDM prediction model had a specificity of 74.5%.
Nigeriagestational diabetes mellitus (GDM)publié 2024BMC pregnancy and childbirthPubMeddocument de 2 observations
61,1 %Overall, 61.1% of people living with HIV on antiretroviral therapy in Nigeria were at risk for cardiovascular disease.
Nigeriamaladies cardiovasculairesobservé 2024publié 2025AIDS research and therapyPubMeddocument de 7 observations
0,036 p_valueTP53 was significantly associated with breast cancer (five cases, zero controls; P = .036).
Nigeriacancer du seinpublié 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 14 observations
59,6 %Invasive candidiasis accounted for 59.6% (n = 68) of the 114 reported IFI cases in the Nigerian paediatric population.
Nigeriainvasive candidiasisobservé 1964–2023publié 2025Journal de mycologie medicalePubMeddocument de 17 observations
2,4 %Sickle Cell Disease was the third leading indirect cause of maternal mortality, accounting for 2.4% of cases.
Nigeriadrépanocytoseobservé 2007-2019publié 2022BMC pregnancy and childbirthPubMeddocument de 10 observations
76,9 %The proportion of respondents with low 10-year risk of developing cardiovascular diseases was 76.9%.
Nigeriamaladies cardiovasculairespublié 2020BMC cardiovascular disordersPubMeddocument de 11 observations
10,8 %Cervical cancer screening prevalence among women aged 30–49 years in Nigeria was 10.8% in the South West region.
Nigeriacancer du col de l'utérusobservé 2023–24PubMeddocument de 3 observations
9,3 %Osteoarthritis was more frequent in subjects with diabetes mellitus (9.3%) than in non-diabetic controls (4.1%).
Nigeriadiabète (non précisé) · osteoarthritispublié 2020ReumatismoPubMeddocument de 8 observations
61 %At the 40% threshold, 61% of the poorest quartile of sickle cell disease patients experienced catastrophic expenditure.
Nigeriadrépanocytosepublié 2022PloS onePubMeddocument de 5 observations
44,9 %Ziziphus mauritiana at the high dose of 0.5 mg/ml caused a reduction in percentage of sickle red cells from 44.9% to 20.5% at 150 minutes.
Nigeriadrépanocytosepublié 2020West African journal of medicineeurope_pmcdocument de 3 observations
39 %Thirty-nine percent of Nigerian patients with non-metastatic T4 breast cancer were triple negative.
NigeriaT4 breast cancerobservé 2010 to 2016publié 2021The oncologistPubMeddocument de 12 observations
17,8 %Thirty-eight (17.8%) of 213 prepandemic samples from Nigeria tested positive on the Euroimmun NCP IgG assay.
NigeriaCOVID-19publié 2021Journal of clinical microbiologyPubMeddocument de 6 observations
71 %Among non-diabetic respondents in a cross-sectional survey, 71.0% of those who had raised blood sugar in the past were at high risk of developing type 2 diabetes.
Nigeriadiabète de type 2publié 2021African health sciencesPubMeddocument de 10 observations
28,87 yearsThe mean age of the sickle cell patients was 28.87 ± 7.89 years.
Nigeriadrépanocytosepublié 2022West African journal of medicinePubMeddocument de 8 observations
0 p_valueProximity to the refinery was significantly associated with hypertension (P ≤ 0.0001).
Nigeriahypertension artériellepublié 2025Nigerian journal of clinical practicePubMeddocument de 6 observations
96,8 %96.8% of women in urban slums of Lagos, Nigeria had not heard about cervical cancer screening.
Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 13 observations
18,8 %The prevalence of diabetes mellitus among respondents was 18.8%.
Nigeriadiabète (non précisé)publié 2020BMC cardiovascular disordersPubMeddocument de 11 observations
3,4 %The prevalence of newly diagnosed diabetes was 3.4% by fasting glucose test among participants surveyed in Ethiopia and Nigeria.
Éthiopie · Nigeriadiabète (non précisé)observé 2020 to 2021publié 2025Journal of diabetesPubMeddocument de 8 observations
12 %In PVR D eyes, improved vision was seen in 12% of Vit.+RT cases.
Nigeriaproliferative vitreoretinopathyobservé 2005–2012publié 2020Nigerian journal of clinical practicePubMeddocument de 11 observations
Clinical recovery from illness occurred in all children.
Nigeriapaludismepublié 2008Journal of infection and chemotherapy : official journal of the Japan Society of Chemothereurope_pmcdocument de 2 observations
90,3 %In 2019, 90.3% of pregnant women receiving antenatal care in Nigeria were screened for HIV.
NigeriaVIH/sidaobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 10 observations
0 p-valueThe mutant pfmdr1Y86 allele was associated with in vivo chloroquine resistance (p=0.000042).
Nigeriapaludismepublié 2006Parasitology researcheurope_pmcdocument de 12 observations
Cervical cancer is the second leading cause of cancer morbidity and mortality among Nigerian women.
Nigeriacancer du col de l'utéruspublié 2023African journal of reproductive healthPubMeddocument de 4 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.